6 x Pharmaceutical Aromasin 25mg x 30

Description

Classification

6 x Pharmaceutical Aromasin 25mg x 30 contains exemestane, a steroidal aromatase inhibitor used as a prescription-only hormonal medicine in the UK. Aromasin is specifically authorised for certain hormone-dependent breast cancer treatments in postmenopausal women. Each tablet contains 25mg of exemestane, making this product a recognised strength for established clinical treatment when prescribed and monitored by an appropriate healthcare professional.

What is 6 x Pharmaceutical Aromasin 25mg x 30?

6 x Pharmaceutical Aromasin 25mg x 30 is a pack presentation containing six packs of Aromasin 25mg tablets, with 30 tablets in each pack. The active ingredient, exemestane, belongs to the aromatase inhibitor family and works by substantially reducing the body’s production of oestrogen.

Aromasin is particularly relevant to postmenopausal women whose breast cancer is hormone-receptor positive. It may be prescribed as part of adjuvant treatment after an initial course of tamoxifen or for advanced breast cancer following progression after anti-oestrogen treatment.

Dosage

For the authorised treatment of breast cancer, the recommended adult and elderly dose of Aromasin is one 25mg tablet once daily, preferably after a meal. The exact duration of treatment depends on the clinical situation and should be determined by the prescribing specialist. For early breast cancer, exemestane may form part of a combined five-year hormonal treatment programme after previous tamoxifen therapy.

Key dosage points include:

• Take the tablet orally.
• The standard authorised dose is 25mg once daily.
• Taking it after food is recommended.
• Do not alter the prescribed dose without medical advice.
• Children and adolescents are not recommended to use exemestane.

How Does 6 x Pharmaceutical Aromasin 25mg x 30 Work?

Aromasin reduces the production of oestrogen in the body. In postmenopausal women, much of the body’s oestrogen is produced when androgen hormones are converted into oestrogens by an enzyme called aromatase. Exemestane blocks this process, producing a significant reduction in circulating oestrogen.

This makes Aromasin useful where the growth of certain breast cancer cells is driven by oestrogen. By lowering oestrogen availability, exemestane helps reduce hormonal stimulation of oestrogen-sensitive cancer cells.

Benefits

When appropriately prescribed, Aromasin offers an established hormonal treatment option for suitable postmenopausal patients with hormone-dependent breast cancer. Its principal clinical benefits include:

• Reducing oestrogen production through aromatase inhibition.
• Supporting adjuvant treatment of certain early breast cancers.
• Providing a treatment option for selected advanced breast cancers.
• Offering an alternative hormonal approach after tamoxifen treatment.
• Convenient once-daily oral administration.

The suitability of treatment depends on the patient’s diagnosis, menopausal status, previous therapy and overall health.

When Should You Not Take 6 x Pharmaceutical Aromasin 25mg x 30?

Aromasin should not be taken by people who are allergic to exemestane or any of its ingredients. It is also contraindicated in premenopausal women and women who are pregnant or breastfeeding. A healthcare professional should establish appropriate menopausal status where there is uncertainty before treatment begins.

It is also important to discuss existing medical conditions and other medicines with the prescriber before starting treatment, particularly where liver, kidney or bone health may require additional monitoring.

What is the Mechanism of 6 x Pharmaceutical Aromasin 25mg x 30?

Exemestane is an irreversible steroidal aromatase inhibitor. It is structurally related to androstenedione and binds to the aromatase enzyme, permanently inactivating it. This prevents the conversion of androgens into oestrogens in peripheral tissues.

At the authorised 25mg daily dose, Aromasin produces substantial suppression of whole-body aromatisation and therefore markedly lowers oestrogen concentrations. This mechanism is central to its role in treating hormone-dependent breast cancer in postmenopausal women.

Uses of 6 x Pharmaceutical Aromasin 25mg x 30

Aromasin has clearly defined clinical uses in the UK. It is authorised for:

• Adjuvant treatment of postmenopausal women with oestrogen-receptor-positive invasive early breast cancer after 2–3 years of initial tamoxifen therapy.
• Treatment of advanced breast cancer in women who are naturally or medically postmenopausal and whose disease has progressed following anti-oestrogen treatment.

Its effectiveness has not been established for oestrogen-receptor-negative disease.

Warnings and Precautions for 6 x Pharmaceutical Aromasin 25mg x 30

Because exemestane powerfully lowers oestrogen, long-term treatment requires appropriate clinical supervision. One important consideration is bone health, as treatment can reduce bone mineral density and increase fracture risk. Patients with osteoporosis or other risk factors may require baseline and ongoing bone-health assessment.

Important precautions include:

• Tell your doctor about osteoporosis or previous fractures.
• Discuss liver or kidney problems before treatment.
• Review all medicines and supplements being taken.
• Avoid oestrogen-containing medicines unless specifically advised.
• Certain CYP3A4-inducing medicines may reduce exemestane effectiveness.
• Vitamin D status may need consideration where clinically appropriate.

Side Effects of 6 x Pharmaceutical Aromasin 25mg x 30

Like all prescription medicines, Aromasin can cause unwanted effects. Commonly reported reactions include hot flushes, joint pain and fatigue. Other effects may include nausea, headache, dizziness, sweating, sleep difficulties and musculoskeletal discomfort.

Potential effects worth discussing with a healthcare professional include:

• Hot flushes and increased sweating.
• Joint or muscle pain.
• Fatigue or weakness.
• Headache or dizziness.
• Nausea and gastrointestinal symptoms.
• Reduced bone mineral density and increased fracture risk.
• Mood or sleep changes.

Severe, persistent or unusual symptoms should be assessed promptly.

Storage for 6 x Pharmaceutical Aromasin 25mg x 30

Keep Aromasin in its original packaging and store it according to the manufacturer’s instructions. Keep the tablets away from excessive heat, moisture and direct sunlight, and store them securely out of the reach of children. Do not use tablets if the packaging is damaged or the medicine is past its expiry date.

As this is a prescription medicine, storage and handling should follow the information supplied with the product and the advice of the dispensing pharmacy.

Where to buy 6 x Pharmaceutical Aromasin 25mg x 30?

To get 6 x Pharmaceutical Aromasin 25mg x 30 online, go to Steroid Sanctuary, today to get the best deal on this medicine .

Frequently Asked Questions

1. What is the active ingredient in Aromasin 25mg?

The active ingredient is exemestane, a steroidal aromatase inhibitor that reduces oestrogen production.

2. What is the usual prescribed dose of Aromasin?

The authorised adult dose is 25mg once daily, preferably after a meal.

3. Who is Aromasin mainly prescribed for?

It is primarily prescribed for appropriate postmenopausal women with hormone-dependent breast cancer, including certain early and advanced breast cancer cases.

4. Can Aromasin affect bone health?

Yes. Because it significantly lowers oestrogen, treatment can reduce bone mineral density and increase fracture risk, so bone health may require monitoring.

5. Can Aromasin be taken during pregnancy?

No. Exemestane is contraindicated during pregnancy and breastfeeding. Women who could potentially become pregnant should discuss appropriate contraception and menopausal status with their healthcare professional.